James F. Polewaczyk, Executive Vice President at IDEXX LABORATORIES INC /DE (IDXX), sold 19,894 shares at $520.19 ($10.4M) on 2023-12-07, disclosed to the SEC on 2023-12-08.
Open-market sale of $10.4M IDXX by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $520.19 | 3,116 | $1.6M | 15.6% |
| 2 | $520.19 | 3,116 | $1.6M | 15.6% |
| 3 | $521.00 | 3,378 | $1.8M | 17.0% |
| 4 | $522.31 | 1,202 | $628K | 6.0% |
| 5 | $522.31 | 1,202 | $628K | 6.0% |
| 6 | $523.56 | 3,940 |
| $2.1M |
| 19.9% |
| 7 | $523.56 | 3,940 | $2.1M | 19.9% |
| Total | $521.92 avg | 19,894 | $10.4M | 100% |
| Filing → |
| IDXX | SELL | 2021-12-01 | $2.9M | — | Filing → |
| IDXX | SELL | 2021-06-01 | $11.2M | — | Filing → |
| IDXX | SELL | 2020-05-12 | $9.7M | — | Filing → |